NYSE:CC - Chemours Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$47.00 +0.39 (+0.84 %)
(As of 06/22/2018 04:00 PM ET)
Previous Close$47.00
Today's Range$46.52 - $47.39
52-Week Range$34.84 - $58.08
Volume2.07 million shs
Average Volume1.66 million shs
Market Capitalization$8.38 billion
P/E Ratio12.30
Dividend Yield1.44%
Beta2.92
Chemours logoThe Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, and industrial fluoropolymer resins and derivatives under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals for gold production, oil and gas, water treatment, electronics, and automotive industries. It also provides sodium cyanide through its mining solutions business; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

Receive CC News and Ratings via Email

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:CC
CUSIPN/A
Phone302-773-1000

Debt

Debt-to-Equity Ratio4.13
Current Ratio2.21
Quick Ratio1.60

Price-To-Earnings

Trailing P/E Ratio12.30
Forward P/E Ratio8.26
P/E Growth0.53

Sales & Book Value

Annual Sales$6.18 billion
Price / Sales1.35
Cash Flow$5.4651 per share
Price / Cash8.60
Book Value$4.67 per share
Price / Book10.06

Profitability

EPS (Most Recent Fiscal Year)$3.82
Net Income$746 million
Net Margins13.79%
Return on Equity107.89%
Return on Assets12.09%

Miscellaneous

Employees7,000
Outstanding Shares177,910,000

Chemours (NYSE:CC) Frequently Asked Questions

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Tuesday, May 1st. Shareholders of record on Thursday, May 17th will be paid a dividend of $0.17 per share on Friday, June 15th. This represents a $0.68 annualized dividend and a dividend yield of 1.45%. The ex-dividend date is Wednesday, May 16th. View Chemours' Dividend History.

How will Chemours' stock buyback program work?

Chemours declared that its board has initiated a share buyback program on Monday, December 4th 2017, which allows the company to repurchase $500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are often an indication that the company's management believes its shares are undervalued.

How were Chemours' earnings last quarter?

Chemours Co (NYSE:CC) issued its earnings results on Thursday, May, 3rd. The specialty chemicals company reported $1.41 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.22 by $0.19. The specialty chemicals company had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.65 billion. Chemours had a net margin of 13.79% and a return on equity of 107.89%. Chemours's revenue was up 20.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.75 earnings per share. View Chemours' Earnings History.

When is Chemours' next earnings date?

Chemours is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for Chemours.

What price target have analysts set for CC?

10 equities research analysts have issued 1 year price objectives for Chemours' stock. Their predictions range from $55.00 to $69.00. On average, they anticipate Chemours' stock price to reach $60.9444 in the next year. View Analyst Ratings for Chemours.

Who are some of Chemours' key competitors?

Who are Chemours' key executives?

Chemours' management team includes the folowing people:
  • Mr. Mark P. Vergnano, Pres, CEO & Director (Age 60)
  • Mr. Mark E. Newman, Sr. VP & CFO (Age 55)
  • Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 61)
  • Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 54)

Has Chemours been receiving favorable news coverage?

Headlines about CC stock have been trending somewhat positive recently, Accern reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Chemours earned a news sentiment score of 0.16 on Accern's scale. They also gave media stories about the specialty chemicals company an impact score of 46.75 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

Who are Chemours' major shareholders?

Chemours' stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (9.88%), Iridian Asset Management LLC CT (2.56%), Prudential Financial Inc. (2.16%), Allianz Asset Management GmbH (1.39%), Allianz Asset Management GmbH (1.39%) and Northern Trust Corp (0.96%). Company insiders that own Chemours stock include Amy Trojanowski, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Paul Kirsch and Richard H Brown. View Institutional Ownership Trends for Chemours.

Which major investors are selling Chemours stock?

CC stock was sold by a variety of institutional investors in the last quarter, including Columbus Circle Investors, Natixis, Hsbc Holdings PLC, JPMorgan Chase & Co., Spark Investment Management LLC, Caisse DE Depot ET Placement DU Quebec, Thrivent Financial for Lutherans and Swiss National Bank. Company insiders that have sold Chemours company stock in the last year include Amy Trojanowski, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano and Paul Kirsch. View Insider Buying and Selling for Chemours.

Which major investors are buying Chemours stock?

CC stock was purchased by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, First Eagle Investment Management LLC, Point72 Asset Management L.P., Millennium Management LLC, Scopus Asset Management L.P., Carillon Tower Advisers Inc., Allianz Asset Management GmbH and Allianz Asset Management GmbH. View Insider Buying and Selling for Chemours.

How do I buy shares of Chemours?

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $47.00.

How big of a company is Chemours?

Chemours has a market capitalization of $8.38 billion and generates $6.18 billion in revenue each year. The specialty chemicals company earns $746 million in net income (profit) each year or $3.82 on an earnings per share basis. Chemours employs 7,000 workers across the globe.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19899. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]


MarketBeat Community Rating for Chemours (CC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  196 (Vote Outperform)
Underperform Votes:  240 (Vote Underperform)
Total Votes:  436
MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.